Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pelvic exenteration from the surgical viewpoint]

P E Goretzki1, P J Goebell, T Vogel

  • 1Klinik für Allgemein- und Unfallchirurgie und Klinik für Frauenheilkunde, Heinriche-Heine Universität Düsseldorf.

Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|February 5, 1999
PubMed
Summary

Pelvic exenteration (PE) is a complex surgery for recurrent rectal or cervical cancer. Early multidisciplinary team cooperation is crucial for optimal patient selection and outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

[Rational follow-up of non-muscle invasive bladder cancer].

Der Urologe. Ausg. A·2021
Same author

[Sectoral interface-an opportunity for health services research?]

Der Urologe. Ausg. A·2020
Same author

[Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC) : The androgen receptor-independent active agent in the therapeutic sequence].

Der Urologe. Ausg. A·2019
Same author

[Guideline adherence].

Der Urologe. Ausg. A·2019

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gynecologic Oncology

Context:

  • Pelvic exenteration (PE) is a radical surgical procedure indicated for advanced or recurrent pelvic malignancies.
  • Specific challenges exist in patient selection and the reconstructive aspects of PE.
  • Close collaboration between gynecologic oncologists, colorectal surgeons, and urologists is essential for successful PE.

Purpose:

  • To delineate the indications and challenges associated with pelvic exenteration for recurrent colorectal and cervical cancers.
  • To emphasize the importance of multidisciplinary input in decision-making for PE.
  • To evaluate the role of intestinal reconstruction in improving quality of life versus associated morbidity.

Summary:

  • Pelvic exenteration is considered for select patients with advanced rectal carcinoma (T3 N1, T4) without distant metastases, potentially offering advantages over chemotherapy.

Related Experiment Videos

  • For cervical cancer recurrence, PE, with or without intestinal reconstruction, is significant. Intestinal reconstruction may enhance quality of life in R0 resections.
  • Reconstructive surgery in pre-treated patients (radiation, prior surgery) carries increased morbidity, leading to reluctance in non-curative settings with limited survival.

    • Impact:

    • Optimizing patient selection for pelvic exenteration can improve survival and quality of life in select oncologic cases.
    • Multidisciplinary approaches in complex pelvic surgeries like PE are vital for achieving optimal oncologic and functional outcomes.
    • Careful consideration of the risks and benefits of reconstructive surgery in PE is necessary, particularly in patients with limited life expectancy.